Hi Everyone 👋,
Welcome to the #58 issue of 247capital — your weekly source of Investment Research. If you are new, you can join my email list here or👇🏻
Please hit the heart button ❤️ if you like today’s letter and reply with any feedback.
Below you’ll find the overview of all bought shares since Issue 1 and the current state. Please keep in mind we’re here for the long run. 5-10 years horizon at least.
$TAP - bought at $44.95 - Issue 1
Closed the week at $54.14 (up 20.44%)🔥
💰$1.06 dividends
$GEO - bought at $5.79 - Issue 7
Closed the week at $6.53 (up 12.78%)🔥
XTRA:DFV - bought at 12.96€ - Issue 8
Closed the week at 11.70€ (down 9.72%)❄️
READ - bought at 39.25SEK - Issue 12+24
Closed the week at 7.12SEK (down 81.85%)❄️
$HIMS - bought at $8.28 - Issue 12+25
Closed the week at $4.21 (down 49.15%)❄️
THG - bought at 373.50pc - Issue 32+36
Closed the week at 107.65 (down 71.17%)❄️
A lot of people with high IQs are terrible investors because they’ve got terrible temperaments.
— Charlie Munger
Douglas A. Boneparth@dougboneparth
This isn’t Netflix, Dogecoin or even Enron. It’s my portfolio.

12:50 PM · Apr 27, 2022
530 Reposts · 8.47K Likes
Charlie Bilello@charliebilello
Price to Earnings Ratios... Clorox $CLX: 74 Kraft Heinz $KHC: 53 Altria $MO: 42 Walmart $WMT: 32 Colgate-Palmolive $CL: 32 PepsiCo $PEP: 32 Hershey $HSY: 31 Coca-Cola $KO: 28 Procter & Gamble $PG: 28 Kroger $KR: 25 S&P 500 $SPY: 21 --- Netflix $NFLX: 17 Facebook $FB: 13
3:10 PM · Apr 27, 2022
218 Reposts · 1.26K Likes
Cassandra B.C.@MichaelJBurry__

5:43 PM · Apr 26, 2022
700 Reposts · 6.18K Likes
Elon Musk@elonmusk
Next I’m buying Coca-Cola to put the cocaine back in
12:56 AM · Apr 28, 2022
704K Reposts · 4.8M Likes
Charlie Bilello@charliebilello
In late 2020, Teladoc bought Livongo for $18.5 billion in cash and stock. Teladoc's market cap is now $5 billion, down 90% from its high. $TDOC
6:39 PM · Apr 28, 2022
42 Reposts · 226 Likes
Thanks for reading, and until next Monday,
Sebastian from 247capital
No posts

Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.